Two additional models of systemic PCPE-1 suppression, i.e., germline Pcolce knockouts or treatment of mice with a PCPE-1 targeted peptide vaccine, provided additional evidence that liver fibrosis could be ameliorated when PCPE-1 activity was antagonized. This evidence concerns the gene PCOLCE and Hepatic fibrosis.